Name of the organization
THE CHILDREN'S HOSPITAL OF PHILADELPHIA
Employer identification number
23-1352166
Part I
General Information on Activities Outside the United States.
Complete if the organization answered "Yes" to Form 990, Part IV, line 14b.
other assistance, the grantees’ eligibility for the grants or assistance, and the selection criteria used
Part II
Grants and Other Assistance to Organizations or Entities Outside the United States.
Complete if the organization answered "Yes" to Form 990, Part IV, line 15, for any recipient who received more than $5,000. Part II can be duplicated if additional space is needed.
1 (a) Name of organization
|
(b) IRS code section and EIN (if applicable) |
(c) Region |
(d) Purpose of grant |
(e) Amount of cash grant |
(f) Manner of cash disbursement |
(g) Amount of non-cash assistance |
(h) Description of non-cash assistance |
(i) Method of valuation (book, FMV, appraisal, other) |
|
|
|
East Asia and the Pacific
|
PEDIATRIC CANCER TRIALS
|
145,967 |
Check
|
|
N/A |
FMV |
|
|
|
East Asia and the Pacific
|
PEDIATRIC CANCER TRIALS
|
52,700 |
Check
|
|
N/A |
FMV |
|
|
|
East Asia and the Pacific
|
PEDIATRIC CANCER TRIALS
|
33,175 |
Check
|
|
N/A |
FMV |
|
|
|
East Asia and the Pacific
|
PEDIATRIC CANCER TRIALS
|
49,200 |
Check
|
|
N/A |
FMV |
|
|
|
East Asia and the Pacific
|
CANCER TRIALS ANBL0931
|
6,000 |
Check
|
|
N/A |
FMV |
|
|
|
East Asia and the Pacific
|
PEDIATRIC CANCER TRIALS
|
122,267 |
Check
|
|
N/A |
FMV |
|
|
|
East Asia and the Pacific
|
PEDIATRIC CANCER TRIALS
|
80,983 |
Check
|
|
N/A |
FMV |
|
|
|
East Asia and the Pacific
|
HYPERINSULINISM STUDY
|
12,500 |
Check
|
|
N/A |
FMV |
|
|
|
East Asia and the Pacific
|
CANCER TRIALS AALL1331
|
22,000 |
Check
|
|
N/A |
FMV |
|
|
|
East Asia and the Pacific
|
PEDIATRIC CANCER TRIALS
|
109,117 |
Check
|
|
N/A |
FMV |
|
|
|
East Asia and the Pacific
|
PEDIATRIC CANCER TRIALS
|
12,775 |
Check
|
|
N/A |
FMV |
|
|
|
East Asia and the Pacific
|
PEDIATRIC CANCER TRIALS
|
20,125 |
Check
|
|
N/A |
FMV |
|
|
|
East Asia and the Pacific
|
SAIL AWARD
|
52,600 |
Check
|
|
N/A |
FMV |
|
|
|
East Asia and the Pacific
|
PEDIATRIC CANCER TRIALS
|
12,100 |
Check
|
|
N/A |
FMV |
|
|
|
Europe
|
BRAIN TUMOR CONSORTIUM
|
25,000 |
Check
|
|
N/A |
FMV |
|
|
|
Europe
|
SAIL AWARD
|
28,800 |
Check
|
|
N/A |
FMV |
|
|
|
Europe
|
HERMANSKY PUDLAK SYND
|
38,083 |
Check
|
|
N/A |
FMV |
|
|
|
Europe
|
NEUROBLASTOMA TUMOR
|
62,215 |
Check
|
|
N/A |
FMV |
|
|
|
Europe
|
SAIL AWARD
|
16,800 |
Check
|
|
N/A |
FMV |
|
|
|
Europe
|
PEDIATRIC CANCER TRIALS
|
61,300 |
Check
|
|
N/A |
FMV |
|
|
|
Europe
|
PEDIATRIC CANCER TRIALS
|
20,200 |
Check
|
|
N/A |
FMV |
|
|
|
Europe
|
GENOME WIDE ASSOCIATION
|
18,186 |
Check
|
|
N/A |
FMV |
|
|
|
Europe
|
ORPHAN DISEASE RESEARCH
|
50,000 |
Check
|
|
N/A |
FMV |
|
|
|
Europe
|
LAMELLAR BODY BIOGENESIS
|
40,673 |
Check
|
|
N/A |
FMV |
|
|
|
Europe
|
SAIL AWARD
|
16,800 |
Check
|
|
N/A |
FMV |
|
|
|
Middle East and North Africa
|
TRANSCATHETER VALVE
|
41,670 |
Check
|
|
N/A |
FMV |
|
|
|
Middle East and North Africa
|
MHCII INFLUENZA STUDY
|
32,400 |
Check
|
|
N/A |
FMV |
|
|
|
North America
|
PEDIATRIC CANCER TRIALS
|
60,258 |
Check
|
|
N/A |
FMV |
|
|
|
North America
|
PEDIATRIC CANCER TRIALS
|
63,650 |
Check
|
|
N/A |
FMV |
|
|
|
North America
|
PEDIATRIC CANCER TRIALS
|
34,500 |
Check
|
|
N/A |
FMV |
|
|
|
North America
|
PEDIATRIC CANCER TRIALS
|
42,900 |
Check
|
|
N/A |
FMV |
|
|
|
North America
|
CANCER TRIALS ALTE11C2
|
16,800 |
Check
|
|
N/A |
FMV |
|
|
|
North America
|
PEDIATRIC CANCER TRIALS
|
79,475 |
Check
|
|
N/A |
FMV |
|
|
|
North America
|
IMMUNOGENOMICS THERAPIES
|
425,700 |
Check
|
|
N/A |
FMV |
|
|
|
North America
|
CANCER TRIALS AAML1031
|
7,500 |
Check
|
|
N/A |
FMV |
|
|
|
North America
|
CANCER TRIALS ACCL1333
|
21,562 |
Check
|
|
N/A |
FMV |
|
|
|
North America
|
PEDIATRIC CANCER TRIALS
|
111,163 |
Check
|
|
N/A |
FMV |
|
|
|
North America
|
PROJECT EVERY CHILD
|
6,100 |
Check
|
|
N/A |
FMV |
|
|
|
North America
|
CANCER TRIALS ALTE11C2
|
7,800 |
Check
|
|
N/A |
FMV |
|
|
|
North America
|
CANCER TRIALS AALL1331
|
9,000 |
Check
|
|
N/A |
FMV |
|
|
|
North America
|
PEDIATRIC CANCER TRIALS
|
52,400 |
Check
|
|
N/A |
FMV |
|
|
|
North America
|
CANCER TRIALS AALL1331
|
22,000 |
Check
|
|
N/A |
FMV |
|
|
|
North America
|
TOXICITY MONITORING TRIAL
|
33,028 |
Check
|
|
N/A |
FMV |
|
|
|
North America
|
IMMUNOGENOMICS THERAPIES
|
223,750 |
Check
|
|
N/A |
FMV |
|
|
|
North America
|
PEDIATRIC CANCER TRIALS
|
717,629 |
Check
|
|
N/A |
FMV |
|
|
|
North America
|
PEDIATRIC CANCER TRIALS
|
112,175 |
Check
|
|
N/A |
fmv |
|
|
|
North America
|
PEDIATRIC CANCER TRIALS
|
12,750 |
Check
|
|
N/A |
FMV |
|
|
|
North America
|
CANCER TRIALS AALL1031
|
8,000 |
Check
|
|
N/A |
FMV |
|
|
|
North America
|
CANCER TRIALS AALL1331
|
28,459 |
Check
|
|
N/A |
FMV |
|
|
|
North America
|
PEDIATRIC CANCER TRIALS
|
85,983 |
Check
|
|
N/A |
FMV |
|
|
|
North America
|
CANCER TRIALS AAML1522
|
6,000 |
Check
|
|
N/A |
FMV |
|
|
|
North America
|
PEDIATRIC CANCER TRIALS
|
80,225 |
Check
|
|
N/A |
FMV |
|
|
|
North America
|
PEDIATRIC CANCER TRIALS
|
12,167 |
Check
|
|
N/A |
FMV |
|
|
|
North America
|
PEDIATRIC CANCER TRIALS
|
29,150 |
Check
|
|
N/A |
FMV |
|
|
|
North America
|
TRANSFUSION THERAPY
|
21,356 |
Check
|
|
N/A |
FMV |
|
|
|
North America
|
EX-/IN-VIVO PLATELETS
|
27,648 |
Check
|
|
N/A |
FMV |
|
|
|
North America
|
SAIL AWARD
|
33,600 |
Check
|
|
N/A |
FMV |
|
|
|
North America
|
PEDIATRIC CANCER TRIALS
|
63,983 |
Check
|
|
N/A |
FMV |
|
|
|
North America
|
PEDIATRIC CANCER TRIALS
|
117,475 |
Check
|
|
N/A |
FMV |
|
|
|
South Asia
|
CLUBFOOT GRANT
|
14,700 |
Wire
|
|
N/A |
FMV |
|
|
|
Sub-Saharan Africa
|
GILEAD HIV RESEARCH
|
19,642 |
Wire
|
|
N/A |
FMV |
|
|
|
Sub-Saharan Africa
|
MEDICATION ADHERENCE HIV
|
23,029 |
Wire
|
|
N/A |
FMV |
2 |
Enter total number of recipient organizations listed above that are recognized as charities by the foreign country,
recognized as tax-exempt by the IRS, or for which the grantee or counsel has provided a section 501(c)(3) equivalency letter
.......
|
9 |
3 |
Enter total number of other organizations or entities
.......................
|
47 |
Schedule F (Form 990) 2016
Schedule F (Form 990) 2016Page 3
Part III
Grants and Other Assistance to Individuals Outside the United States.
Complete if the organization answered "Yes" to Form 990, Part IV, line 16.Part III can be duplicated if additional space is needed.
(a) Type of grant or assistance |
(b) Region |
(c) Number of recipients |
(d) Amount of cash grant |
(e) Manner of cash disbursement |
(f) Amount of non-cash assistance |
(g) Description of non-cash assistance |
(h) Method of valuation (book, FMV, appraisal, other) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Schedule F (Form 990) 2016
Schedule F (Form 990) 2016
Page 4
1 |
Was the organization a U.S. transferor of property to a foreign corporation during the tax year?
If "Yes,"the organization may be required to file Form 926, Return by a U.S. Transferor of Property
to a Foreign Corporation (see Instructions for Form 926).
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
|
|
|
2 |
Did the organization have an interest in a foreign trust during the tax year?
If "Yes," the organization may be required to separately file Form 3520, Annual Return to
Report Transactions with Foreign Trusts and Receipt of Certain Foreign Gifts, and/or
Form 3520-A, Annual Information Return of Foreign Trust With a U.S. Owner (see
Instructions for Forms 3520 and 3520-A; do not file with Form 990).
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
|
|
|
3 |
Did the organization have an ownership interest in a foreign corporation during the tax year? If "Yes," the organization may be
required to file Form 5471, Information Return of U.S. Persons with Respect to Certain Foreign Corporations. (see Instructions
for Form 5471).
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
|
|
|
4 |
Was the organization a direct or indirect shareholder of a passive foreign investment company or a
qualified electing fund during the tax year? If “Yes,” the organization may be required to file Form 8621,
Information Return by a Shareholder of a Passive Foreign Investment Company or Qualified Electing
Fund. (see Instructions for Form 8621) .
|
|
|
5 |
Did the organization have an ownership interest in a foreign partnership during the tax year? If "Yes," the organization
may be required to file Form 8865, Return of U.S. Persons with Respect to Certain Foreign Partnerships (see Instructions for Form 8865).
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
|
|
|
6 |
Did the organization have any operations in or related to any boycotting countries during the tax year? If "Yes," the
organization may be required to separately file Form 5713, International Boycott Report (see Instructions for Form 5713; do not file with Form 990)..
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
|
|
|
|
Schedule F (Form 990) 2016
Schedule F (Form 990) 2016
Page 5
Part V
Supplemental Information
Provide the information required by Part I, line 2 (monitoring of funds); Part I, line 3, column (f) (accounting method; amounts of investments vs. expenditures per region); Part II, line 1 (accounting method); Part III (accounting method); and Part III, column (c) (estimated number of recipients), as applicable. Also complete this part to provide any additional information (see instructions).
ReturnReference |
Explanation |
SCHEDULE F, PART I, LINE 2 |
MONITORING PROCEDURES: THE CHILDREN'S HOSPITAL OF PHILADELPHIA HAS ESTABLISHED CONTROLS IN PLACE TO MONITOR THE USE OF GRANT FUNDS BOTH OUTSIDE AND WITHIN THE UNITED STATES. EXPENDITURES ARE MONITORED BASED ON THE GUIDELINES OUTLINED BY 45 CFR PART 74 APPENDIX E (OASC-3). IT IS OUR POLICY TO FOLLOW THE FEDERAL GOVERNMENT-ESTABLISHED PRINCIPLES FOR DETERMINING COSTS APPLICABLE TO GRANTS, CONTRACTS, AND OTHER AGREEMENTS. THE HOSPITAL GENERALLY APPLIES THESE SAME COST PRINCIPLES TO NON-FEDERAL FUNDING. ALL COSTS POSTED TO SPONSORED PROJECTS MUST COMPLY WITH GOVERNMENT AND SPONSOR RULES AND REGULATIONS. COSTS MUST MEET SEVERAL CRITERIA: (1) COSTS BEING CHARGED TO A GRANT MUST BE REASONABLE AND NECESSARY FOR MEETING THE OBJECTIVES OF THE GRANT/PROJECT, (2) COSTS MUST BE ALLOWABLE IN ACCORDANCE WITH THE SPONSOR RULES AND REGULATIONS, (3) COSTS MUST BE ALLOCABLE BASED ON THE BENEFIT DERVIED, CAUSE AND EFFECT OR OTHER EQUITABLE RELATIONSHIP, AND (4) COSTS MUST BE CONSISTENT WITH COSTS CHARGED IN SIMILAR CIRCUMSTANCES TO OTHER SPONSORED PROJECTS. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Schedule F (Form 990) 2016
Software ID: |
|
Software Version: |
|